nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolbutamide—CYP2C18—prostate cancer	0.239	0.69	CbGaD
Tolbutamide—CYP2C19—prostate cancer	0.107	0.31	CbGaD
Tolbutamide—SLCO2B1—Estrone—prostate cancer	0.0656	0.14	CbGbCtD
Tolbutamide—SLCO2B1—Conjugated Estrogens—prostate cancer	0.0429	0.0914	CbGbCtD
Tolbutamide—SLCO2B1—Estradiol—prostate cancer	0.0377	0.0802	CbGbCtD
Tolbutamide—SLCO1A2—Estrone—prostate cancer	0.0359	0.0766	CbGbCtD
Tolbutamide—CYP2C8—Nilutamide—prostate cancer	0.024	0.051	CbGbCtD
Tolbutamide—SLCO1A2—Conjugated Estrogens—prostate cancer	0.0235	0.0501	CbGbCtD
Tolbutamide—SLCO1A2—Estradiol—prostate cancer	0.0206	0.044	CbGbCtD
Tolbutamide—CYP2C19—Nilutamide—prostate cancer	0.0201	0.0428	CbGbCtD
Tolbutamide—CYP2C19—Bicalutamide—prostate cancer	0.0201	0.0428	CbGbCtD
Tolbutamide—CYP2C8—Abiraterone—prostate cancer	0.0199	0.0423	CbGbCtD
Tolbutamide—SLCO1A2—Prednisone—prostate cancer	0.0178	0.0378	CbGbCtD
Tolbutamide—CYP2C9—Bicalutamide—prostate cancer	0.0167	0.0356	CbGbCtD
Tolbutamide—CYP2C9—Nilutamide—prostate cancer	0.0167	0.0356	CbGbCtD
Tolbutamide—CYP2C19—Flutamide—prostate cancer	0.0167	0.0355	CbGbCtD
Tolbutamide—CYP2C8—Cabazitaxel—prostate cancer	0.0147	0.0313	CbGbCtD
Tolbutamide—SLC22A6—Conjugated Estrogens—prostate cancer	0.0143	0.0304	CbGbCtD
Tolbutamide—CYP2C8—Ethinyl Estradiol—prostate cancer	0.0128	0.0272	CbGbCtD
Tolbutamide—CYP2C9—Estrone—prostate cancer	0.01	0.0213	CbGbCtD
Tolbutamide—CYP2C8—Estradiol—prostate cancer	0.00824	0.0176	CbGbCtD
Tolbutamide—CYP2C9—Capecitabine—prostate cancer	0.00759	0.0162	CbGbCtD
Tolbutamide—CYP2C19—Estradiol—prostate cancer	0.00692	0.0147	CbGbCtD
Tolbutamide—CYP2C19—Prednisone—prostate cancer	0.00595	0.0127	CbGbCtD
Tolbutamide—ABCC8—penis—prostate cancer	0.00576	0.225	CbGeAlD
Tolbutamide—CYP2C9—Estradiol—prostate cancer	0.00575	0.0122	CbGbCtD
Tolbutamide—CYP2C8—Etoposide—prostate cancer	0.00538	0.0115	CbGbCtD
Tolbutamide—Alcohol intolerance—Nilutamide—prostate cancer	0.0044	0.0632	CcSEcCtD
Tolbutamide—Porphyria cutanea tarda—Estradiol—prostate cancer	0.00384	0.0551	CcSEcCtD
Tolbutamide—Porphyria non-acute—Estradiol—prostate cancer	0.0036	0.0517	CcSEcCtD
Tolbutamide—CYP2C19—urine—prostate cancer	0.00221	0.0865	CbGeAlD
Tolbutamide—Jaundice cholestatic—Estrone—prostate cancer	0.00171	0.0246	CcSEcCtD
Tolbutamide—CYP2C9—urine—prostate cancer	0.00171	0.067	CbGeAlD
Tolbutamide—KCNJ1—renal system—prostate cancer	0.00168	0.0657	CbGeAlD
Tolbutamide—Jaundice cholestatic—Flutamide—prostate cancer	0.00159	0.0228	CcSEcCtD
Tolbutamide—Jaundice cholestatic—Estradiol valerate/Dienogest—prostate cancer	0.0015	0.0215	CcSEcCtD
Tolbutamide—ABCC8—prostate gland—prostate cancer	0.00138	0.0538	CbGeAlD
Tolbutamide—ABCC8—seminal vesicle—prostate cancer	0.00116	0.0455	CbGeAlD
Tolbutamide—Haemolytic anaemia—Flutamide—prostate cancer	0.00112	0.0161	CcSEcCtD
Tolbutamide—SLCO2B1—prostate gland—prostate cancer	0.00108	0.0421	CbGeAlD
Tolbutamide—Reaction gastrointestinal—Docetaxel—prostate cancer	0.00108	0.0154	CcSEcCtD
Tolbutamide—SLC15A1—epithelium—prostate cancer	0.000967	0.0378	CbGeAlD
Tolbutamide—Abdominal distension—Estrone—prostate cancer	0.000952	0.0137	CcSEcCtD
Tolbutamide—Pancytopenia—Estramustine—prostate cancer	0.00094	0.0135	CcSEcCtD
Tolbutamide—ABCC8—renal system—prostate cancer	0.000938	0.0367	CbGeAlD
Tolbutamide—Eruption—Estradiol—prostate cancer	0.000906	0.013	CcSEcCtD
Tolbutamide—SLC15A1—renal system—prostate cancer	0.000897	0.0351	CbGeAlD
Tolbutamide—Abdominal distension—Estradiol valerate/Dienogest—prostate cancer	0.000831	0.0119	CcSEcCtD
Tolbutamide—SLC15A2—prostate gland—prostate cancer	0.000823	0.0322	CbGeAlD
Tolbutamide—Photosensitivity reaction—Flutamide—prostate cancer	0.000798	0.0115	CcSEcCtD
Tolbutamide—Jaundice cholestatic—Conjugated Estrogens—prostate cancer	0.000792	0.0114	CcSEcCtD
Tolbutamide—Hypoglycaemia—Bicalutamide—prostate cancer	0.000752	0.0108	CcSEcCtD
Tolbutamide—Abdominal distension—Cabazitaxel—prostate cancer	0.000744	0.0107	CcSEcCtD
Tolbutamide—SLCO2B1—renal system—prostate cancer	0.000734	0.0287	CbGeAlD
Tolbutamide—SLC15A2—seminal vesicle—prostate cancer	0.000696	0.0272	CbGeAlD
Tolbutamide—SLCO1A2—renal system—prostate cancer	0.000676	0.0264	CbGeAlD
Tolbutamide—Jaundice cholestatic—Estradiol—prostate cancer	0.000634	0.0091	CcSEcCtD
Tolbutamide—Leukopenia—Estramustine—prostate cancer	0.000617	0.00886	CcSEcCtD
Tolbutamide—Erythema—Flutamide—prostate cancer	0.000609	0.00874	CcSEcCtD
Tolbutamide—ABCC8—testis—prostate cancer	0.000606	0.0237	CbGeAlD
Tolbutamide—Eruption—Docetaxel—prostate cancer	0.000583	0.00837	CcSEcCtD
Tolbutamide—Gliclazide—VEGFA—prostate cancer	0.000568	0.306	CrCbGaD
Tolbutamide—SLC15A2—renal system—prostate cancer	0.000561	0.0219	CbGeAlD
Tolbutamide—Thrombocytopenia—Estramustine—prostate cancer	0.000551	0.00791	CcSEcCtD
Tolbutamide—SLC15A2—urethra—prostate cancer	0.000551	0.0215	CbGeAlD
Tolbutamide—Leukopenia—Nilutamide—prostate cancer	0.000548	0.00786	CcSEcCtD
Tolbutamide—Erythema—Degarelix—prostate cancer	0.000547	0.00784	CcSEcCtD
Tolbutamide—Leukopenia—Flutamide—prostate cancer	0.000545	0.00783	CcSEcCtD
Tolbutamide—Abdominal distension—Ethinyl Estradiol—prostate cancer	0.000539	0.00774	CcSEcCtD
Tolbutamide—Heartburn—Docetaxel—prostate cancer	0.000521	0.00748	CcSEcCtD
Tolbutamide—Erythema—Cabazitaxel—prostate cancer	0.000515	0.00739	CcSEcCtD
Tolbutamide—Thrombocytopenia—Flutamide—prostate cancer	0.000487	0.00699	CcSEcCtD
Tolbutamide—Dyspepsia—Abiraterone—prostate cancer	0.000481	0.00691	CcSEcCtD
Tolbutamide—KCNJ11—lymph node—prostate cancer	0.000477	0.0187	CbGeAlD
Tolbutamide—SLCO2B1—testis—prostate cancer	0.000475	0.0186	CbGeAlD
Tolbutamide—CYP2C8—renal system—prostate cancer	0.000472	0.0185	CbGeAlD
Tolbutamide—Gastrointestinal disorder—Abiraterone—prostate cancer	0.000472	0.00677	CcSEcCtD
Tolbutamide—Leukopenia—Cabazitaxel—prostate cancer	0.000461	0.00661	CcSEcCtD
Tolbutamide—Abdominal distension—Conjugated Estrogens—prostate cancer	0.00044	0.00631	CcSEcCtD
Tolbutamide—Dyspepsia—Nilutamide—prostate cancer	0.00044	0.00631	CcSEcCtD
Tolbutamide—SLCO1A2—testis—prostate cancer	0.000437	0.0171	CbGeAlD
Tolbutamide—Gastrointestinal disorder—Nilutamide—prostate cancer	0.000431	0.00619	CcSEcCtD
Tolbutamide—Urticaria—Estrone—prostate cancer	0.000427	0.00613	CcSEcCtD
Tolbutamide—Dyspepsia—Estradiol valerate/Dienogest—prostate cancer	0.000413	0.00593	CcSEcCtD
Tolbutamide—Thrombocytopenia—Cabazitaxel—prostate cancer	0.000411	0.00591	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Estradiol valerate/Dienogest—prostate cancer	0.000405	0.00581	CcSEcCtD
Tolbutamide—Photosensitivity reaction—Goserelin—prostate cancer	0.000402	0.00578	CcSEcCtD
Tolbutamide—Pruritus—Estramustine—prostate cancer	0.000398	0.00571	CcSEcCtD
Tolbutamide—Eruption—Epirubicin—prostate cancer	0.000394	0.00565	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Degarelix—prostate cancer	0.000385	0.00553	CcSEcCtD
Tolbutamide—Pruritus—Estrone—prostate cancer	0.00038	0.00546	CcSEcCtD
Tolbutamide—Hyponatraemia—Mitoxantrone—prostate cancer	0.000378	0.00543	CcSEcCtD
Tolbutamide—Urticaria—Estradiol valerate/Dienogest—prostate cancer	0.000373	0.00535	CcSEcCtD
Tolbutamide—Dyspepsia—Cabazitaxel—prostate cancer	0.00037	0.00531	CcSEcCtD
Tolbutamide—Eruption—Doxorubicin—prostate cancer	0.000364	0.00523	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Cabazitaxel—prostate cancer	0.000363	0.00521	CcSEcCtD
Tolbutamide—SLC15A2—testis—prostate cancer	0.000362	0.0142	CbGeAlD
Tolbutamide—Rash—Estramustine—prostate cancer	0.000355	0.00509	CcSEcCtD
Tolbutamide—Urticaria—Degarelix—prostate cancer	0.000354	0.00509	CcSEcCtD
Tolbutamide—Pruritus—Nilutamide—prostate cancer	0.000353	0.00507	CcSEcCtD
Tolbutamide—Thrombocytopenia—Bicalutamide—prostate cancer	0.000353	0.00507	CcSEcCtD
Tolbutamide—Headache—Estramustine—prostate cancer	0.000353	0.00506	CcSEcCtD
Tolbutamide—Abdominal distension—Estradiol—prostate cancer	0.000352	0.00505	CcSEcCtD
Tolbutamide—Pruritus—Flutamide—prostate cancer	0.000352	0.00505	CcSEcCtD
Tolbutamide—Rash—Abiraterone—prostate cancer	0.000345	0.00495	CcSEcCtD
Tolbutamide—SLCO2B1—lymph node—prostate cancer	0.000344	0.0135	CbGeAlD
Tolbutamide—Rash—Estrone—prostate cancer	0.000339	0.00487	CcSEcCtD
Tolbutamide—Headache—Estrone—prostate cancer	0.000337	0.00483	CcSEcCtD
Tolbutamide—Nausea—Estramustine—prostate cancer	0.000334	0.0048	CcSEcCtD
Tolbutamide—Pruritus—Estradiol valerate/Dienogest—prostate cancer	0.000332	0.00476	CcSEcCtD
Tolbutamide—Probenecid—SLC22A1—prostate cancer	0.000322	0.173	CrCbGaD
Tolbutamide—Nausea—Estrone—prostate cancer	0.000319	0.00458	CcSEcCtD
Tolbutamide—Photosensitivity reaction—Estradiol—prostate cancer	0.000319	0.00458	CcSEcCtD
Tolbutamide—Dyspepsia—Bicalutamide—prostate cancer	0.000317	0.00455	CcSEcCtD
Tolbutamide—Pruritus—Degarelix—prostate cancer	0.000316	0.00453	CcSEcCtD
Tolbutamide—Rash—Nilutamide—prostate cancer	0.000315	0.00452	CcSEcCtD
Tolbutamide—Rash—Flutamide—prostate cancer	0.000313	0.0045	CcSEcCtD
Tolbutamide—Headache—Nilutamide—prostate cancer	0.000313	0.00449	CcSEcCtD
Tolbutamide—Headache—Flutamide—prostate cancer	0.000311	0.00447	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Bicalutamide—prostate cancer	0.000311	0.00447	CcSEcCtD
Tolbutamide—Pancytopenia—Mitoxantrone—prostate cancer	0.000309	0.00444	CcSEcCtD
Tolbutamide—Erythema—Goserelin—prostate cancer	0.000307	0.00441	CcSEcCtD
Tolbutamide—CYP2C8—testis—prostate cancer	0.000305	0.0119	CbGeAlD
Tolbutamide—Erythema—Conjugated Estrogens—prostate cancer	0.000304	0.00437	CcSEcCtD
Tolbutamide—Nausea—Nilutamide—prostate cancer	0.000297	0.00426	CcSEcCtD
Tolbutamide—Rash—Estradiol valerate/Dienogest—prostate cancer	0.000296	0.00425	CcSEcCtD
Tolbutamide—Nausea—Flutamide—prostate cancer	0.000295	0.00424	CcSEcCtD
Tolbutamide—Headache—Estradiol valerate/Dienogest—prostate cancer	0.000294	0.00422	CcSEcCtD
Tolbutamide—Urticaria—Bicalutamide—prostate cancer	0.000286	0.00411	CcSEcCtD
Tolbutamide—Rash—Degarelix—prostate cancer	0.000281	0.00404	CcSEcCtD
Tolbutamide—Headache—Degarelix—prostate cancer	0.000279	0.00401	CcSEcCtD
Tolbutamide—Haemolytic anaemia—Capecitabine—prostate cancer	0.000279	0.00401	CcSEcCtD
Tolbutamide—Nausea—Estradiol valerate/Dienogest—prostate cancer	0.000279	0.004	CcSEcCtD
Tolbutamide—Jaundice cholestatic—Epirubicin—prostate cancer	0.000275	0.00395	CcSEcCtD
Tolbutamide—Gliclazide—CYP2C19—prostate cancer	0.000275	0.148	CrCbGaD
Tolbutamide—Leukopenia—Goserelin—prostate cancer	0.000275	0.00395	CcSEcCtD
Tolbutamide—Agranulocytosis—Mitoxantrone—prostate cancer	0.000271	0.00389	CcSEcCtD
Tolbutamide—Nausea—Degarelix—prostate cancer	0.000265	0.0038	CcSEcCtD
Tolbutamide—Headache—Cabazitaxel—prostate cancer	0.000263	0.00378	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Ethinyl Estradiol—prostate cancer	0.000263	0.00378	CcSEcCtD
Tolbutamide—SLC15A2—lymph node—prostate cancer	0.000263	0.0103	CbGeAlD
Tolbutamide—Hyponatraemia—Docetaxel—prostate cancer	0.000262	0.00375	CcSEcCtD
Tolbutamide—Pancytopenia—Etoposide—prostate cancer	0.000257	0.00369	CcSEcCtD
Tolbutamide—Pruritus—Bicalutamide—prostate cancer	0.000255	0.00366	CcSEcCtD
Tolbutamide—Jaundice cholestatic—Doxorubicin—prostate cancer	0.000255	0.00366	CcSEcCtD
Tolbutamide—Hyponatraemia—Capecitabine—prostate cancer	0.000253	0.00363	CcSEcCtD
Tolbutamide—Nausea—Cabazitaxel—prostate cancer	0.00025	0.00358	CcSEcCtD
Tolbutamide—Thrombocytopenia—Goserelin—prostate cancer	0.000246	0.00352	CcSEcCtD
Tolbutamide—Erythema—Estradiol—prostate cancer	0.000244	0.0035	CcSEcCtD
Tolbutamide—Urticaria—Ethinyl Estradiol—prostate cancer	0.000242	0.00347	CcSEcCtD
Tolbutamide—Rash—Bicalutamide—prostate cancer	0.000227	0.00326	CcSEcCtD
Tolbutamide—Aplastic anaemia—Epirubicin—prostate cancer	0.000227	0.00326	CcSEcCtD
Tolbutamide—Erythema—Mitoxantrone—prostate cancer	0.000227	0.00326	CcSEcCtD
Tolbutamide—Headache—Bicalutamide—prostate cancer	0.000226	0.00324	CcSEcCtD
Tolbutamide—Agranulocytosis—Etoposide—prostate cancer	0.000225	0.00324	CcSEcCtD
Tolbutamide—Dyspepsia—Goserelin—prostate cancer	0.000221	0.00317	CcSEcCtD
Tolbutamide—Abdominal distension—Capecitabine—prostate cancer	0.000219	0.00315	CcSEcCtD
Tolbutamide—Dyspepsia—Conjugated Estrogens—prostate cancer	0.000219	0.00314	CcSEcCtD
Tolbutamide—Pruritus—Ethinyl Estradiol—prostate cancer	0.000216	0.00309	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Conjugated Estrogens—prostate cancer	0.000214	0.00308	CcSEcCtD
Tolbutamide—Nausea—Bicalutamide—prostate cancer	0.000214	0.00307	CcSEcCtD
Tolbutamide—Chlorpropamide—CYP2C19—prostate cancer	0.000214	0.115	CrCbGaD
Tolbutamide—Pancytopenia—Docetaxel—prostate cancer	0.000214	0.00307	CcSEcCtD
Tolbutamide—Aplastic anaemia—Doxorubicin—prostate cancer	0.00021	0.00302	CcSEcCtD
Tolbutamide—Pancytopenia—Capecitabine—prostate cancer	0.000207	0.00297	CcSEcCtD
Tolbutamide—Leukopenia—Mitoxantrone—prostate cancer	0.000203	0.00292	CcSEcCtD
Tolbutamide—Urticaria—Goserelin—prostate cancer	0.000199	0.00286	CcSEcCtD
Tolbutamide—Photosensitivity reaction—Capecitabine—prostate cancer	0.000199	0.00286	CcSEcCtD
Tolbutamide—Urticaria—Conjugated Estrogens—prostate cancer	0.000197	0.00283	CcSEcCtD
Tolbutamide—Abdominal distension—Prednisone—prostate cancer	0.000195	0.00281	CcSEcCtD
Tolbutamide—Rash—Ethinyl Estradiol—prostate cancer	0.000192	0.00276	CcSEcCtD
Tolbutamide—Headache—Ethinyl Estradiol—prostate cancer	0.000191	0.00274	CcSEcCtD
Tolbutamide—Glipizide—CYP3A4—prostate cancer	0.000188	0.101	CrCbGaD
Tolbutamide—Agranulocytosis—Docetaxel—prostate cancer	0.000187	0.00269	CcSEcCtD
Tolbutamide—Agranulocytosis—Capecitabine—prostate cancer	0.000181	0.0026	CcSEcCtD
Tolbutamide—Thrombocytopenia—Mitoxantrone—prostate cancer	0.000181	0.0026	CcSEcCtD
Tolbutamide—Nausea—Ethinyl Estradiol—prostate cancer	0.000181	0.0026	CcSEcCtD
Tolbutamide—Hypoglycaemia—Epirubicin—prostate cancer	0.00018	0.00258	CcSEcCtD
Tolbutamide—Pruritus—Goserelin—prostate cancer	0.000177	0.00255	CcSEcCtD
Tolbutamide—Probenecid—CYP2C19—prostate cancer	0.000177	0.0953	CrCbGaD
Tolbutamide—Hyponatraemia—Epirubicin—prostate cancer	0.000176	0.00253	CcSEcCtD
Tolbutamide—Pruritus—Conjugated Estrogens—prostate cancer	0.000176	0.00252	CcSEcCtD
Tolbutamide—Dyspepsia—Estradiol—prostate cancer	0.000175	0.00251	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Estradiol—prostate cancer	0.000172	0.00246	CcSEcCtD
Tolbutamide—Leukopenia—Etoposide—prostate cancer	0.000169	0.00243	CcSEcCtD
Tolbutamide—Hypoglycaemia—Doxorubicin—prostate cancer	0.000167	0.00239	CcSEcCtD
Tolbutamide—Hyponatraemia—Doxorubicin—prostate cancer	0.000163	0.00234	CcSEcCtD
Tolbutamide—Dyspepsia—Mitoxantrone—prostate cancer	0.000163	0.00234	CcSEcCtD
Tolbutamide—Rash—Goserelin—prostate cancer	0.000158	0.00227	CcSEcCtD
Tolbutamide—Urticaria—Estradiol—prostate cancer	0.000158	0.00227	CcSEcCtD
Tolbutamide—Headache—Goserelin—prostate cancer	0.000157	0.00225	CcSEcCtD
Tolbutamide—Erythema—Docetaxel—prostate cancer	0.000157	0.00225	CcSEcCtD
Tolbutamide—Rash—Conjugated Estrogens—prostate cancer	0.000157	0.00225	CcSEcCtD
Tolbutamide—Headache—Conjugated Estrogens—prostate cancer	0.000156	0.00223	CcSEcCtD
Tolbutamide—Abdominal distension—Epirubicin—prostate cancer	0.000153	0.00219	CcSEcCtD
Tolbutamide—Erythema—Capecitabine—prostate cancer	0.000152	0.00218	CcSEcCtD
Tolbutamide—Thrombocytopenia—Etoposide—prostate cancer	0.000151	0.00217	CcSEcCtD
Tolbutamide—Nausea—Goserelin—prostate cancer	0.000149	0.00214	CcSEcCtD
Tolbutamide—Nausea—Conjugated Estrogens—prostate cancer	0.000148	0.00212	CcSEcCtD
Tolbutamide—Urticaria—Mitoxantrone—prostate cancer	0.000147	0.00211	CcSEcCtD
Tolbutamide—Pancytopenia—Epirubicin—prostate cancer	0.000144	0.00207	CcSEcCtD
Tolbutamide—Abdominal distension—Doxorubicin—prostate cancer	0.000141	0.00203	CcSEcCtD
Tolbutamide—Pruritus—Estradiol—prostate cancer	0.000141	0.00202	CcSEcCtD
Tolbutamide—Leukopenia—Docetaxel—prostate cancer	0.00014	0.00202	CcSEcCtD
Tolbutamide—Photosensitivity reaction—Epirubicin—prostate cancer	0.000139	0.00199	CcSEcCtD
Tolbutamide—Leukopenia—Capecitabine—prostate cancer	0.000136	0.00195	CcSEcCtD
Tolbutamide—Erythema—Prednisone—prostate cancer	0.000135	0.00194	CcSEcCtD
Tolbutamide—Pancytopenia—Doxorubicin—prostate cancer	0.000133	0.00192	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Etoposide—prostate cancer	0.000133	0.00191	CcSEcCtD
Tolbutamide—Photosensitivity reaction—Doxorubicin—prostate cancer	0.000128	0.00184	CcSEcCtD
Tolbutamide—Agranulocytosis—Epirubicin—prostate cancer	0.000126	0.00181	CcSEcCtD
Tolbutamide—Thrombocytopenia—Docetaxel—prostate cancer	0.000125	0.0018	CcSEcCtD
Tolbutamide—Rash—Estradiol—prostate cancer	0.000125	0.0018	CcSEcCtD
Tolbutamide—Headache—Estradiol—prostate cancer	0.000125	0.00179	CcSEcCtD
Tolbutamide—Urticaria—Etoposide—prostate cancer	0.000122	0.00176	CcSEcCtD
Tolbutamide—Thrombocytopenia—Capecitabine—prostate cancer	0.000121	0.00174	CcSEcCtD
Tolbutamide—Nausea—Estradiol—prostate cancer	0.000118	0.00169	CcSEcCtD
Tolbutamide—Agranulocytosis—Doxorubicin—prostate cancer	0.000117	0.00168	CcSEcCtD
Tolbutamide—Rash—Mitoxantrone—prostate cancer	0.000117	0.00168	CcSEcCtD
Tolbutamide—Headache—Mitoxantrone—prostate cancer	0.000116	0.00167	CcSEcCtD
Tolbutamide—Dyspepsia—Docetaxel—prostate cancer	0.000113	0.00162	CcSEcCtD
Tolbutamide—Probenecid—CYP3A4—prostate cancer	0.000112	0.0606	CrCbGaD
Tolbutamide—Gastrointestinal disorder—Docetaxel—prostate cancer	0.000111	0.00159	CcSEcCtD
Tolbutamide—Nausea—Mitoxantrone—prostate cancer	0.00011	0.00158	CcSEcCtD
Tolbutamide—Dyspepsia—Capecitabine—prostate cancer	0.000109	0.00157	CcSEcCtD
Tolbutamide—Pruritus—Etoposide—prostate cancer	0.000109	0.00156	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Capecitabine—prostate cancer	0.000107	0.00154	CcSEcCtD
Tolbutamide—Erythema—Epirubicin—prostate cancer	0.000106	0.00152	CcSEcCtD
Tolbutamide—Urticaria—Capecitabine—prostate cancer	9.85e-05	0.00141	CcSEcCtD
Tolbutamide—Erythema—Doxorubicin—prostate cancer	9.79e-05	0.00141	CcSEcCtD
Tolbutamide—Dyspepsia—Prednisone—prostate cancer	9.72e-05	0.0014	CcSEcCtD
Tolbutamide—Rash—Etoposide—prostate cancer	9.71e-05	0.00139	CcSEcCtD
Tolbutamide—Headache—Etoposide—prostate cancer	9.65e-05	0.00139	CcSEcCtD
Tolbutamide—Leukopenia—Epirubicin—prostate cancer	9.47e-05	0.00136	CcSEcCtD
Tolbutamide—Nausea—Etoposide—prostate cancer	9.15e-05	0.00131	CcSEcCtD
Tolbutamide—Pruritus—Docetaxel—prostate cancer	9.06e-05	0.0013	CcSEcCtD
Tolbutamide—Urticaria—Prednisone—prostate cancer	8.77e-05	0.00126	CcSEcCtD
Tolbutamide—Pruritus—Capecitabine—prostate cancer	8.77e-05	0.00126	CcSEcCtD
Tolbutamide—Leukopenia—Doxorubicin—prostate cancer	8.76e-05	0.00126	CcSEcCtD
Tolbutamide—Thrombocytopenia—Epirubicin—prostate cancer	8.46e-05	0.00121	CcSEcCtD
Tolbutamide—Rash—Docetaxel—prostate cancer	8.07e-05	0.00116	CcSEcCtD
Tolbutamide—Headache—Docetaxel—prostate cancer	8.02e-05	0.00115	CcSEcCtD
Tolbutamide—Thrombocytopenia—Doxorubicin—prostate cancer	7.82e-05	0.00112	CcSEcCtD
Tolbutamide—Rash—Capecitabine—prostate cancer	7.82e-05	0.00112	CcSEcCtD
Tolbutamide—Pruritus—Prednisone—prostate cancer	7.81e-05	0.00112	CcSEcCtD
Tolbutamide—Headache—Capecitabine—prostate cancer	7.77e-05	0.00111	CcSEcCtD
Tolbutamide—Nausea—Docetaxel—prostate cancer	7.61e-05	0.00109	CcSEcCtD
Tolbutamide—Dyspepsia—Epirubicin—prostate cancer	7.6e-05	0.00109	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Epirubicin—prostate cancer	7.46e-05	0.00107	CcSEcCtD
Tolbutamide—Nausea—Capecitabine—prostate cancer	7.36e-05	0.00106	CcSEcCtD
Tolbutamide—Dyspepsia—Doxorubicin—prostate cancer	7.03e-05	0.00101	CcSEcCtD
Tolbutamide—Rash—Prednisone—prostate cancer	6.96e-05	0.000999	CcSEcCtD
Tolbutamide—Headache—Prednisone—prostate cancer	6.92e-05	0.000993	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Doxorubicin—prostate cancer	6.9e-05	0.00099	CcSEcCtD
Tolbutamide—Urticaria—Epirubicin—prostate cancer	6.86e-05	0.000985	CcSEcCtD
Tolbutamide—Nausea—Prednisone—prostate cancer	6.56e-05	0.000941	CcSEcCtD
Tolbutamide—Urticaria—Doxorubicin—prostate cancer	6.35e-05	0.000911	CcSEcCtD
Tolbutamide—Pruritus—Epirubicin—prostate cancer	6.11e-05	0.000877	CcSEcCtD
Tolbutamide—Pruritus—Doxorubicin—prostate cancer	5.65e-05	0.000811	CcSEcCtD
Tolbutamide—Rash—Epirubicin—prostate cancer	5.45e-05	0.000782	CcSEcCtD
Tolbutamide—Headache—Epirubicin—prostate cancer	5.41e-05	0.000777	CcSEcCtD
Tolbutamide—Nausea—Epirubicin—prostate cancer	5.13e-05	0.000736	CcSEcCtD
Tolbutamide—Rash—Doxorubicin—prostate cancer	5.04e-05	0.000723	CcSEcCtD
Tolbutamide—Headache—Doxorubicin—prostate cancer	5.01e-05	0.000719	CcSEcCtD
Tolbutamide—Nausea—Doxorubicin—prostate cancer	4.75e-05	0.000681	CcSEcCtD
Tolbutamide—CYP2C18—Metabolism—CAV1—prostate cancer	5.25e-06	6.02e-05	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—PIK3CD—prostate cancer	5.23e-06	6e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	5.22e-06	5.98e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—GSTA4—prostate cancer	5.21e-06	5.98e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—TBXAS1—prostate cancer	5.21e-06	5.98e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—LRP2—prostate cancer	5.2e-06	5.97e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—PLCB2—prostate cancer	5.2e-06	5.97e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—CYP2C18—prostate cancer	5.2e-06	5.97e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—TCN2—prostate cancer	5.19e-06	5.96e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—UCP3—prostate cancer	5.19e-06	5.96e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—PDHA1—prostate cancer	5.19e-06	5.96e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—GSTA3—prostate cancer	5.19e-06	5.96e-05	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—CYP1A1—prostate cancer	5.17e-06	5.93e-05	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—ERCC2—prostate cancer	5.13e-06	5.88e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—P4HB—prostate cancer	5.1e-06	5.85e-05	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—NOS3—prostate cancer	5.09e-06	5.84e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	5.09e-06	5.84e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—GSTA2—prostate cancer	5.08e-06	5.82e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—SULT1A1—prostate cancer	5.02e-06	5.75e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—ABCG5—prostate cancer	5.02e-06	5.75e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—SLC22A1—prostate cancer	4.96e-06	5.69e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—HSD3B1—prostate cancer	4.96e-06	5.68e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—SLC22A3—prostate cancer	4.96e-06	5.68e-05	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—NOS3—prostate cancer	4.94e-06	5.67e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	4.91e-06	5.63e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—GSTA1—prostate cancer	4.9e-06	5.62e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—HSD3B2—prostate cancer	4.84e-06	5.56e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—GSTO1—prostate cancer	4.84e-06	5.56e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—NAT2—prostate cancer	4.84e-06	5.56e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—SULT2A1—prostate cancer	4.84e-06	5.55e-05	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—MTHFR—prostate cancer	4.82e-06	5.53e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—LPL—prostate cancer	4.81e-06	5.51e-05	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—PIK3CG—prostate cancer	4.78e-06	5.48e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—MED12—prostate cancer	4.76e-06	5.46e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—GSTA4—prostate cancer	4.75e-06	5.45e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—TBXAS1—prostate cancer	4.75e-06	5.45e-05	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—PPARA—prostate cancer	4.73e-06	5.42e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—GNG5—prostate cancer	4.72e-06	5.41e-05	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—PIK3CB—prostate cancer	4.7e-06	5.39e-05	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—PTGS2—prostate cancer	4.66e-06	5.34e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	4.66e-06	5.34e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—PLCB2—prostate cancer	4.64e-06	5.33e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—LRP2—prostate cancer	4.64e-06	5.33e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—CYP2C18—prostate cancer	4.64e-06	5.33e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	4.64e-06	5.33e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—GSTA2—prostate cancer	4.63e-06	5.31e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—ABCG5—prostate cancer	4.57e-06	5.24e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—SULT1A1—prostate cancer	4.57e-06	5.24e-05	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—PIK3CB—prostate cancer	4.56e-06	5.23e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—P4HB—prostate cancer	4.55e-06	5.22e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—NCOA3—prostate cancer	4.55e-06	5.22e-05	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—INS—prostate cancer	4.53e-06	5.19e-05	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—PTGS2—prostate cancer	4.52e-06	5.18e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	4.47e-06	5.13e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—GSTA1—prostate cancer	4.47e-06	5.12e-05	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—CAV1—prostate cancer	4.45e-06	5.1e-05	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—CREBBP—prostate cancer	4.43e-06	5.08e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—SLC22A1—prostate cancer	4.43e-06	5.08e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—NAT2—prostate cancer	4.42e-06	5.07e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—HSD3B2—prostate cancer	4.42e-06	5.07e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—GSTO1—prostate cancer	4.42e-06	5.07e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	4.38e-06	5.02e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—HPGDS—prostate cancer	4.34e-06	4.98e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—SULT2A1—prostate cancer	4.32e-06	4.95e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—CYP2C19—prostate cancer	4.31e-06	4.94e-05	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	4.25e-06	4.87e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—MED12—prostate cancer	4.25e-06	4.87e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	4.25e-06	4.87e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—LRP2—prostate cancer	4.23e-06	4.86e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—PLCB2—prostate cancer	4.23e-06	4.86e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—CYP2C18—prostate cancer	4.23e-06	4.86e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—GNG5—prostate cancer	4.21e-06	4.83e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—GSTT1—prostate cancer	4.21e-06	4.83e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—ACHE—prostate cancer	4.21e-06	4.83e-05	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—PIK3CD—prostate cancer	4.2e-06	4.82e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—CYP2A6—prostate cancer	4.16e-06	4.77e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—P4HB—prostate cancer	4.15e-06	4.76e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	4.14e-06	4.75e-05	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—PTEN—prostate cancer	4.06e-06	4.66e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—NCOA3—prostate cancer	4.06e-06	4.66e-05	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—PIK3CG—prostate cancer	4.05e-06	4.64e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—AKR1C3—prostate cancer	4.05e-06	4.64e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—SLC22A1—prostate cancer	4.04e-06	4.63e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—PRKACB—prostate cancer	4.02e-06	4.62e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	3.99e-06	4.58e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	3.99e-06	4.57e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—CYP17A1—prostate cancer	3.98e-06	4.57e-05	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—NOS3—prostate cancer	3.97e-06	4.55e-05	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—PTEN—prostate cancer	3.94e-06	4.52e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—SULT2A1—prostate cancer	3.94e-06	4.51e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	3.93e-06	4.51e-05	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—EP300—prostate cancer	3.88e-06	4.44e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—MED12—prostate cancer	3.87e-06	4.44e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—HPGDS—prostate cancer	3.87e-06	4.44e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—GNG5—prostate cancer	3.84e-06	4.41e-05	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—INS—prostate cancer	3.83e-06	4.4e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—NCOA2—prostate cancer	3.8e-06	4.35e-05	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—EP300—prostate cancer	3.76e-06	4.31e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—ACHE—prostate cancer	3.76e-06	4.31e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—GSTT1—prostate cancer	3.76e-06	4.31e-05	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—CREBBP—prostate cancer	3.75e-06	4.31e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—CYP2A6—prostate cancer	3.71e-06	4.26e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—NCOA3—prostate cancer	3.7e-06	4.24e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	3.7e-06	4.24e-05	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—PIK3CB—prostate cancer	3.66e-06	4.2e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	3.64e-06	4.17e-05	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—PTGS2—prostate cancer	3.63e-06	4.16e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—SLC5A5—prostate cancer	3.62e-06	4.15e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—AKR1C3—prostate cancer	3.61e-06	4.14e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—PRKACB—prostate cancer	3.59e-06	4.12e-05	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—PIK3CD—prostate cancer	3.56e-06	4.08e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—CYP17A1—prostate cancer	3.56e-06	4.08e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—CYP2E1—prostate cancer	3.54e-06	4.06e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—HPGDS—prostate cancer	3.53e-06	4.05e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—CYP2C19—prostate cancer	3.51e-06	4.02e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	3.51e-06	4.02e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—NQO1—prostate cancer	3.5e-06	4.01e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—TH—prostate cancer	3.45e-06	3.95e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—GSTT1—prostate cancer	3.42e-06	3.93e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—ACHE—prostate cancer	3.42e-06	3.93e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	3.42e-06	3.93e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—CYP3A4—prostate cancer	3.41e-06	3.91e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	3.39e-06	3.89e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—NCOA2—prostate cancer	3.39e-06	3.89e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—CYP2A6—prostate cancer	3.38e-06	3.88e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	3.37e-06	3.87e-05	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—NOS3—prostate cancer	3.36e-06	3.86e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—CYP1B1—prostate cancer	3.35e-06	3.84e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—AKR1C3—prostate cancer	3.29e-06	3.78e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—PRKACB—prostate cancer	3.28e-06	3.76e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—GGT1—prostate cancer	3.25e-06	3.72e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—CYP17A1—prostate cancer	3.24e-06	3.72e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—SLC5A5—prostate cancer	3.23e-06	3.71e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—NCOA1—prostate cancer	3.2e-06	3.67e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	3.2e-06	3.67e-05	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—PTEN—prostate cancer	3.17e-06	3.63e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—CYP2E1—prostate cancer	3.16e-06	3.62e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—CYP19A1—prostate cancer	3.15e-06	3.62e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—NQO1—prostate cancer	3.12e-06	3.58e-05	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—PIK3CB—prostate cancer	3.1e-06	3.56e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—NCOA2—prostate cancer	3.09e-06	3.54e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—TH—prostate cancer	3.08e-06	3.53e-05	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—PTGS2—prostate cancer	3.07e-06	3.53e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	3.06e-06	3.51e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—CYP3A4—prostate cancer	3.04e-06	3.49e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—RXRA—prostate cancer	3.04e-06	3.49e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	3.03e-06	3.47e-05	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—EP300—prostate cancer	3.02e-06	3.46e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—CYP1B1—prostate cancer	2.99e-06	3.43e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	2.96e-06	3.39e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—SLC5A5—prostate cancer	2.95e-06	3.38e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—COMT—prostate cancer	2.93e-06	3.36e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—GSTP1—prostate cancer	2.92e-06	3.34e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—GGT1—prostate cancer	2.9e-06	3.32e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—CYP2E1—prostate cancer	2.88e-06	3.3e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—ITPR1—prostate cancer	2.87e-06	3.29e-05	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—PIK3CA—prostate cancer	2.87e-06	3.29e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—NCOA1—prostate cancer	2.85e-06	3.27e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—NQO1—prostate cancer	2.85e-06	3.26e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—EP300—prostate cancer	2.82e-06	3.24e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—CYP19A1—prostate cancer	2.81e-06	3.23e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—TH—prostate cancer	2.8e-06	3.22e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	2.79e-06	3.2e-05	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—PIK3CA—prostate cancer	2.78e-06	3.19e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—CYP3A4—prostate cancer	2.78e-06	3.18e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	2.76e-06	3.17e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—CYP1B1—prostate cancer	2.73e-06	3.13e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—RXRA—prostate cancer	2.72e-06	3.11e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—TYMS—prostate cancer	2.71e-06	3.11e-05	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—PTEN—prostate cancer	2.68e-06	3.08e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—GSTM1—prostate cancer	2.68e-06	3.07e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—GGT1—prostate cancer	2.64e-06	3.03e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	2.64e-06	3.03e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—LPL—prostate cancer	2.63e-06	3.02e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—COMT—prostate cancer	2.62e-06	3e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—GSTP1—prostate cancer	2.6e-06	2.99e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—NCOA1—prostate cancer	2.6e-06	2.99e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—CYP19A1—prostate cancer	2.57e-06	2.94e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—ITPR1—prostate cancer	2.56e-06	2.94e-05	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—EP300—prostate cancer	2.56e-06	2.93e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—CYP1A1—prostate cancer	2.54e-06	2.91e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—ERCC2—prostate cancer	2.52e-06	2.89e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—EP300—prostate cancer	2.52e-06	2.89e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—RXRA—prostate cancer	2.48e-06	2.84e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—TYMS—prostate cancer	2.42e-06	2.78e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	2.41e-06	2.76e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—GSTM1—prostate cancer	2.39e-06	2.74e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—COMT—prostate cancer	2.38e-06	2.74e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—GSTP1—prostate cancer	2.37e-06	2.72e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—MTHFR—prostate cancer	2.37e-06	2.72e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—LPL—prostate cancer	2.35e-06	2.69e-05	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—AKT1—prostate cancer	2.34e-06	2.69e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—ITPR1—prostate cancer	2.34e-06	2.68e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—PPARA—prostate cancer	2.32e-06	2.67e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—EP300—prostate cancer	2.3e-06	2.63e-05	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—AKT1—prostate cancer	2.27e-06	2.6e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—CYP1A1—prostate cancer	2.27e-06	2.6e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—ERCC2—prostate cancer	2.25e-06	2.58e-05	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—PIK3CA—prostate cancer	2.23e-06	2.56e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—TYMS—prostate cancer	2.21e-06	2.53e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—CAV1—prostate cancer	2.18e-06	2.51e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—GSTM1—prostate cancer	2.18e-06	2.5e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—LPL—prostate cancer	2.14e-06	2.46e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—MTHFR—prostate cancer	2.11e-06	2.42e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	2.09e-06	2.39e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—PPARA—prostate cancer	2.07e-06	2.38e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—CYP1A1—prostate cancer	2.07e-06	2.37e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—ERCC2—prostate cancer	2.05e-06	2.35e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—PIK3CG—prostate cancer	1.99e-06	2.28e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—CAV1—prostate cancer	1.95e-06	2.24e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—MTHFR—prostate cancer	1.93e-06	2.21e-05	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—PIK3CA—prostate cancer	1.89e-06	2.17e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—PPARA—prostate cancer	1.89e-06	2.17e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—INS—prostate cancer	1.88e-06	2.16e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.86e-06	2.14e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—CREBBP—prostate cancer	1.85e-06	2.12e-05	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—AKT1—prostate cancer	1.82e-06	2.09e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—CAV1—prostate cancer	1.78e-06	2.04e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—PIK3CG—prostate cancer	1.78e-06	2.04e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—PIK3CD—prostate cancer	1.75e-06	2.01e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.7e-06	1.95e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—INS—prostate cancer	1.68e-06	1.93e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—NOS3—prostate cancer	1.65e-06	1.89e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—CREBBP—prostate cancer	1.65e-06	1.89e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—PIK3CG—prostate cancer	1.62e-06	1.86e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—PIK3CD—prostate cancer	1.56e-06	1.79e-05	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—AKT1—prostate cancer	1.55e-06	1.77e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—INS—prostate cancer	1.53e-06	1.76e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—PIK3CB—prostate cancer	1.52e-06	1.75e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—PTGS2—prostate cancer	1.51e-06	1.73e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—CREBBP—prostate cancer	1.5e-06	1.72e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—NOS3—prostate cancer	1.47e-06	1.69e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—PIK3CD—prostate cancer	1.42e-06	1.63e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—PIK3CB—prostate cancer	1.36e-06	1.56e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—PTGS2—prostate cancer	1.35e-06	1.55e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—NOS3—prostate cancer	1.34e-06	1.54e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—PTEN—prostate cancer	1.32e-06	1.51e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—EP300—prostate cancer	1.26e-06	1.44e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—PIK3CB—prostate cancer	1.24e-06	1.42e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—PTGS2—prostate cancer	1.23e-06	1.41e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—PTEN—prostate cancer	1.18e-06	1.35e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—EP300—prostate cancer	1.12e-06	1.29e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—PTEN—prostate cancer	1.07e-06	1.23e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—EP300—prostate cancer	1.02e-06	1.17e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—PIK3CA—prostate cancer	9.3e-07	1.07e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—PIK3CA—prostate cancer	8.3e-07	9.52e-06	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—AKT1—prostate cancer	7.59e-07	8.71e-06	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—PIK3CA—prostate cancer	7.57e-07	8.68e-06	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—AKT1—prostate cancer	6.78e-07	7.77e-06	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—AKT1—prostate cancer	6.18e-07	7.09e-06	CbGpPWpGaD
